Fig. 2.

Flow of patients through the PREDIAPS study (following the CONSORT extension for cluster trials). Note: FP, family physician; IHO, integrated healthcare organization; NP, nurse practitioner; ≥ 30 years, patient aged ≥ 30 years that attended their family physician at least once; No T2D, patients without registered diagnosis of type 2 diabetes; CVRF, patients with a cardiovascular risk factor (e.g., overweight or obese patients with normal glucose levels); IFG, patients with impaired fasting glucose level at any visit during the program implementation period